| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |